Prognostic value of red blood cell distribution width for patients with heart failure: A systematic review and meta-analysis of cohort studies

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Huang, Yuan Lan ^a,b,c   Hu, Zhi De ^a,c   Liu, Shi Jian ^d   Sun, Yi ^b   Qin, Qin ^b   Qin, Bao Dong ^c   Zhang, Wei Wei ^b   Zhang, Jian Rong ^b   Zhong, Ren Qian ^c   Deng, An Mei ^b  

^a Department of Laboratory Medicine NO 455 Hospital of People's Liberation Army ^*  (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; DISEASE ASSOCIATION; ERYTHROCYTE DISTRIBUTION WIDTH; ERYTHROCYTE PARAMETERS; ERYTHROCYTE VOLUME; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; OUTCOME ASSESSMENT; PROGNOSIS; PUBLISHING; REVIEW; SYSTEMATIC REVIEW; ERYTHROCYTE; MEAN CORPUSCULAR VOLUME; META ANALYSIS; MORTALITY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SURVIVAL;

COHORT STUDIES; ERYTHROCYTE INDICES; ERYTHROCYTES; HEART FAILURE; HUMANS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 84922443583     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104861     Document Type: Review

References (51)

1. Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8: 30-41.
2. Nair AP, Timoh T, Fuster V (2012) Contemporary medical management of systolic heart failure. Circ J 76: 268-277.
3. Haddad H, Mielniczuk L, Davies RA (2012) Recent advances in the management of chronic heart failure. Curr Opin Cardiol 27: 161-168.
4. Thakur V, Fouron JC, Mertens L, Jaeggi ET (2013) Diagnosis and management of fetal heart failure. Can J Cardiol 29: 759-767.
5. Baggish AL, van Kimmenade RR, Pinto Y, Richards AM, Lainchbury J, et al. (2010) New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis. Biomarkers 15: 307-314.
6. Ahmad T, Fiuzat M, Felker GM, O'Connor C (2012) Novel biomarkers in chronic heart failure. Nat Rev Cardiol 9: 347-359.
7. Maisel AS, Choudhary R (2012) Biomarkers in acute heart failure-state of the art. Nat Rev Cardiol 9: 478-490.
8. Evans TC, Jehle D (1991) The red blood cell distribution width. J Emerg Med 9 Suppl 1: 71-74.
9. Lin CK, Lin JS, Chen SY, Jiang ML, Chiu CF (1992) Comparison of hemoglobin and red blood cell distribution width in the differential diagnosis of microcytic anemia. Arch Pathol Lab Med 116: 1030-1032.
10. Lou Y, Wang M, Mao W (2012) Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One 7: e37644.
11. Hu Z, Sun Y, Wang Q, Han Z, Huang Y, et al. (2013) Red blood cell distribution width is a potential prognostic index for liver disease. Clin Chem Lab Med 51: 1403-1408.
12. Yesil A, Senates E, Bayoglu IV, Erdem ED, Demirtunc R, et al. (2011) Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut Liver 5: 460-467.
13. Hu ZD, Chen Y, Zhang L, Sun Y, Huang YL, et al. (2013) Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus. Clin Chim Acta 425: 202-205.
14. Ozsu S, Abul Y, Gunaydin S, Orem A, Ozlu T (2012) Prognostic Value of Red Cell Distribution Width in Patients With Pulmonary Embolism. Clin Appl Thromb Hemost.
15. Nathan SD, Reffett T, Brown AW, Fischer CP, Shlobin OA, et al. (2012) The Red Cell Distribution Width as a Prognostic Indicator in IPF. Chest.
16. Kim J, Kim YD, Song TJ, Park JH, Lee HS, et al. (2012) Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction. Thromb Haemost 108: 349-356.
17. Ani C, Ovbiagele B (2009) Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 277: 103-108.
18. Zhang Z, Xu X, Ni H, Deng H (2013) Red cell distribution width is associated with hospital mortality in unselected critically ill patients. J Thorac Dis 5: 730-736.
19. Wang F, PanW, Pan S, Ge J, Wang S, et al. (2011) Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med 43: 40-46.
20. Montagnana M, Cervellin G, Meschi T, Lippi G (2012) The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med 50: 635-641.
21. Wells G (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: http://www.ohrica/ programs/clinical-epidemiology/oxford.asp. Accessed 2013 November 25.
22. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264-269, W264.
23. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
24. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, et al. (2010) Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 16: 230-238.
25. Al-Najjar Y, Goode KM, Zhang J, Cleland JG, Clark AL (2009) Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail 11: 1155-1162.
26. Aung N, Ling HZ, Cheng AS, Aggarwal S, Flint J, et al. (2013) Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol.
27. Bonaque JC, Pascual-Figal DA, Manzano-Fernandez S, Gonzalez-Canovas C, Vidal A, et al. (2012) Red blood cell distribution width adds prognostic value for outpatients with chronic heart failure. Rev Esp Cardiol (Engl Ed) 65: 606-612.
28. Cauthen CA, Tong W, Jain A, Tang WH (2012) Progressive rise in red cell distribution width is associated with disease progression in ambulatory patients with chronic heart failure. J Card Fail 18: 146-152.
29. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, et al. (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50: 40-47. (Pubitemid 46963527)
30. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, et al. (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158: 659-666.
31. Jackson CE, Dalzell JR, Bezlyak V, Tsorlalis IK, Myles RC, et al. (2009) Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail 11: 1152-1154.
32. Jung C, Fujita B, Lauten A, Kiehntopf M, Kuthe F, et al. (2011) Red blood cell distribution width as useful tool to predict long-term mortality in patients with chronic heart failure. Int J Cardiol 152: 417-418.
33. Makhoul BF, Khourieh A, Kaplan M, Bahouth F, Aronson D, et al. (2013) Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol 167: 1412-1416.
34. Oh J, Kang SM, Won H, Hong N, Kim SY, et al. (2012) Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients. Circ J 76: 109-116.
35. Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, et al. (2009) Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 11: 840-846.
36. Rickard J, Kumbhani DJ, Gorodeski EZ, Martin DO, Grimm RA, et al. (2012) Elevated red cell distribution width is associated with impaired reverse ventricular remodeling and increased mortality in patients undergoing cardiac resynchronization therapy. Congest Heart Fail 18: 79-84.
37. van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, et al. (2010) Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 12: 129-136.
38. Zalawadiya SK, Zmily H, Farah J, Daifallah S, Ali O, et al. (2011) Red cell distribution width and mortality in predominantly African-American population with decompensated heart failure. J Card Fail 17: 292-298.
39. Holmstrom A, Sigurjonsdottir R, Hammarsten O, Petzold M, Gustafsson D, et al. (2013) An integrated multiple marker modality is superior to NT-proBNP alone in prognostic prediction in all-cause mortality in a prospective cohort of elderly heart failure patients. Eur Geriatr Med.
40. Simbaqueba C, Shrestha K, Patarroyo M, Troughton RW, Borowski AG, et al. (2013) Prognostic implications of relative hypochromia in ambulatory patients with chronic systolic heart failure. Congest Heart Fail 19: 180-185.
41. Yndestad A, Damas JK, Oie E, Ueland T, Gullestad L, et al. (2007) Role of inflammation in the progression of heart failure. Curr Cardiol Rep 9: 236-241. (Pubitemid 46784419)
42. Chen W, Frangogiannis NG (2010) The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev 15: 415-422.
43. Bozkurt B, Mann DL, Deswal A (2010) Biomarkers of inflammation in heart failure. Heart Fail Rev 15: 331-341.
44. Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY (2013) Suppression of erythropoiesis in patients with chronic heart failure and anaemia of unknown origin: evidence of an immune basis. Int J Cardiol 166: 664-671.
45. Spiropoulos A, Goussetis E, Margeli A, Premetis E, Skenderi K, et al. (2010) Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis. Clin Chem Lab Med 48: 199-203.
46. Pierce CN, Larson DF (2005) Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20: 83-90. (Pubitemid 40691877)
47. Lappe JM, Horne BD, Shah SH, May HT, Muhlestein JB, et al. (2011) Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clinica Chimica Acta 412: 2094-2099.
48. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, et al. (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133: 628-632.
49. Shemin D, Rittenberg D (1946) The life span of the human red blood cell. J Biol Chem 166: 627-636.
50. Ruskoaho H (2003) Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24: 341-356.
51. Vanderheyden M, Bartunek J, Goethals M (2004) Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 6: 261-268. (Pubitemid 38253044)